Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

326 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diabetes, smoking, alcohol use, and family history of cancer as risk factors for pancreatic neuroendocrine tumors: a systematic review and meta-analysis.
Haugvik SP, Hedenström P, Korsæth E, Valente R, Hayes A, Siuka D, Maisonneuve P, Gladhaug IP, Lindkvist B, Capurso G. Haugvik SP, et al. Among authors: capurso g. Neuroendocrinology. 2015;101(2):133-42. doi: 10.1159/000375164. Epub 2015 Jan 22. Neuroendocrinology. 2015. PMID: 25613442 Free article. Review.
Gastric neuroendocrine tumors.
Delle Fave G, Capurso G, Annibale B, Panzuto F. Delle Fave G, et al. Among authors: capurso g. Neuroendocrinology. 2004;80 Suppl 1:16-9. doi: 10.1159/000080734. Neuroendocrinology. 2004. PMID: 15477710 Review.
Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: a position paper from the Italian Registry.
Del Chiaro M, Zerbi A, Capurso G, Zamboni G, Maisonneuve P, Presciuttini S, Arcidiacono PG, Calculli L, Falconi M; Italian Registry for Familial Pancreatic Cancer. Del Chiaro M, et al. Among authors: capurso g. Dig Liver Dis. 2010 Sep;42(9):597-605. doi: 10.1016/j.dld.2010.04.016. Epub 2010 Jun 2. Dig Liver Dis. 2010. PMID: 20627831
Risk factors for disease progression in advanced jejunoileal neuroendocrine tumors.
Panzuto F, Campana D, Fazio N, Brizzi MP, Boninsegna L, Nori F, Di Meglio G, Capurso G, Scarpa A, Dogliotti L, De Braud F, Tomassetti P, Delle Fave G, Falconi M. Panzuto F, et al. Among authors: capurso g. Neuroendocrinology. 2012;96(1):32-40. doi: 10.1159/000334038. Epub 2011 Dec 28. Neuroendocrinology. 2012. PMID: 22205326
Molecular pathology and genetics of pancreatic endocrine tumours.
Capurso G, Festa S, Valente R, Piciucchi M, Panzuto F, Jensen RT, Delle Fave G. Capurso G, et al. J Mol Endocrinol. 2012 Jun 26;49(1):R37-50. doi: 10.1530/JME-12-0069. Print 2012 Aug. J Mol Endocrinol. 2012. PMID: 22586144 Review.
Early onset pancreatic cancer: risk factors, presentation and outcome.
Piciucchi M, Capurso G, Valente R, Larghi A, Archibugi L, Signoretti M, Stigliano S, Zerboni G, Barucca V, La Torre M, Cavallini M, Costamagna G, Marchetti P, Ziparo V, Delle Fave G. Piciucchi M, et al. Among authors: capurso g. Pancreatology. 2015 Mar-Apr;15(2):151-5. doi: 10.1016/j.pan.2015.01.013. Epub 2015 Feb 12. Pancreatology. 2015. PMID: 25708929
SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival.
Mohelnikova-Duchonova B, Strouhal O, Hughes DJ, Holcatova I, Oliverius M, Kala Z, Campa D, Rizzato C, Canzian F, Pezzilli R, Talar-Wojnarowska R, Malecka-Panas E, Sperti C, Federico Zambon C, Pedrazzoli S, Fogar P, Milanetto AC, Capurso G, Delle Fave G, Valente R, Gazouli M, Malleo G, Teresa Lawlor R, Strobel O, Hackert T, Giese N, Vodicka P, Vodickova L, Landi S, Tavano F, Gioffreda D, Piepoli A, Pazienza V, Mambrini A, Pedata M, Cantore M, Bambi F, Ermini S, Funel N, Lemstrova R, Soucek P. Mohelnikova-Duchonova B, et al. Among authors: capurso g. Sci Rep. 2017 Mar 8;7:43812. doi: 10.1038/srep43812. Sci Rep. 2017. PMID: 28272475 Free PMC article.
326 results